Anonymous
Not logged in
Talk
Contributions
Create account
Log in
Search
Editing
Andrew Lloyd
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Namespaces
Page
Discussion
More
More
Page actions
Read
Edit
Edit source
History
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
[[File:Andrew Lloyd.png|200px|thumb|right|Source:UNSW Sydney]] '''Andrew R. Lloyd''', MB BS Syd, MD UNSW, FRACP, is an infectious disease physician, and an epidemiology, virology and immunology researcher. He is a professor at the School of Medical Sciences, University of New South Wales, Sydney, [[Australia]].<ref>https://medicalsciences.med.unsw.edu.au/people/professor-andrew-lloyd</ref> He is one of the authors of the 2002 Australian [[chronic fatigue syndrome]] (CFS) guidelines, which were immediately criticized by ME/CFS Australia<ref>{{Cite web | url = http://sacfs.asn.au/about/guidelines/letter_mar_7.htm | title = ME/CFS Australia (SA) Inc: Letter to eMJA (March 7, 2002) | website = sacfs.asn.au | access-date = 2018-10-02}}</ref> who stated the guidelines: * do not describe accurately and fully the symptoms and characteristics of the illness; * misrepresent the illness and people with [[Chronic fatigue syndrome|CFS]]; * do not provide an accurate, balanced and objective consideration of the research evidence; * demonstrate a consistent bias towards a psychiatric-psychological approach to the illness; * dismiss, downplay or ignore biological evidence; * make illness management suggestions that are potentially harmful for many with CFS; and * do not mention other ways of effectively managing the illness.<ref>{{Cite web | url = http://sacfs.asn.au/about/guidelines/letter_mar_7.htm | title = ME/CFS Australia (SA) Inc: Letter to eMJA (March 7, 2002) | website = sacfs.asn.au | access-date = 2018-10-02}}</ref> In a following letter to the [[Medical Journal of Australia|''Medical Journal of Australia'']], ME/CFS Australia stated: "Following an extensive review of the literature, it is considered that the evidence is not good enough for the ''Guidelines'' to be called ‘evidence-based,’ the assessment and presentation of the evidence has not been objective, the Working Group was not truly representative and so the end product is unreliable. The document provides potentially harmfulmanagement suggestions with insufficient supporting evidence."<ref>{{Cite web | url = http://sacfs.asn.au/about/guidelines/letter_apr_24.htm | title = ME/CFS Australia (SA) Inc: Letter to eMJA (April 24, 2002) | website = sacfs.asn.au | access-date = 2018-10-02}}</ref> More than 700 people signed a petition<ref>{{Cite news |url =https://my.meaction.net/petitions/stop-graded-exercise-therapy-trial-at-university-of-nsw | title = Stop graded exercise therapy trial at University of NSW|work=#MEAction | access-date = 2018-10-02|language=en}}</ref> asking him to stop the roll out of training medical professionals to use [[Cognitive behavioral therapy|CBT]] and [[Graded exercise therapy|GET]] on people diagnosed with chronic fatigue syndrome. The university responded, stating the people who are protesting harbour ‘resentment against the notion that CFS may have psychological causes’<ref>{{Cite news |url =https://meaustralia.net/2017/03/30/unsw-school-of-medicine-responds-cbtget-training-trial-for-chronic-fatigue-syndrome/ | title = Lloyd’s university responds: CBT/GET training trial for chronic fatigue syndrome | date = 2017-03-30|work=ME Australia | access-date = 2018-10-02|language=en-US}}</ref>, while there is no evidence for their argument'''.''' Lloyd is on the Australian government's [[Myalgic encephalomyelitis|ME]] and CFS advisory committee<ref>{{Cite news |url =https://meaustralia.net/2018/04/23/australian-governments-me-and-cfs-advisory-committee/ | title = Australian government’s ME and CFS advisory committee | date = 2018-04-23|work=ME Australia | access-date = 2018-10-02|language=en-US}}</ref>. Lloyd described the [[PACE trial]] has having "reasonably solid data".<ref>{{Cite news |url =https://meaustralia.net/2016/03/31/how-the-unsw-chronic-fatigue-syndrome-studies-use-potentially-harmful-guidelines/ | title = How the UNSW chronic fatigue syndrome studies use ‘potentially harmful’ guidelines | date = 2016-03-31|work=ME Australia | access-date = 2018-10-02|language=en-US}}</ref> ==Awards== *Member, Order of Australia (A.M): “For service to medicine and the community, particularly through provision of hepatitis services in prisons, and research in infectious diseases”<ref>https://medicalsciences.med.unsw.edu.au/people/professor-andrew-lloyd</ref> ==Clinic== *[http://www.fatiguecentre.com.au/ The Fatigue Centre], Newtown, New South Wales, Australia, was created and is supervised by Dr. Andrew Lloyd to serve patients with CFS and post-cancer fatigue. *[[David Tuller]] met with patients of the clinic, who 'reported that their experience included some positive and some very negative aspects'.<ref>{{Cite web | url = http://www.virology.ws/2018/04/04/trial-by-error-a-post-about-andrew-lloyd/ | title = Trial By Error: A Post About Andrew Lloyd | website = [[Virology blog]]|language=en-US | access-date = 2018-10-02}}</ref> ==Book Chapters== *1999, "Chronic fatigue syndrome: current concepts of pathogenesis and treatment," in ''Current Clinical Topics in Infectious Diseases'', edn. Original<ref>Current Clinical Topics in Infectious Diseases, edn. Original, Blackwell Science Asia, Carlton, Victoria, pp. 138 - 159</ref> *2005, "Fatigue states following infection," in ''Infectious Diseases A clinical approach'', edn. 2<ref>Yung A; McDonald M; Spelman D; Street A; Johnson P; Sorrell T; McCormack J (ed.), Infectious Diseases A clinical approach, edn. 2, IP Communications, East Hawthorn, Victoria, Australia, pp. 195 - 204</ref> ==Notable studies== *1990, A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome<ref name="lloyd1990" /> *1997, [[Intravenous immunoglobulin]] is ineffective in the treatment of patients with chronic fatigue syndrome<ref>{{Cite journal | last = Vollmer-Conna | first = U | author-link = Uté Vollmer-Conna | last2 = Hickie | first2 = I | last3 = Hadzi-Pavlovic | first3 = D | last4 = Tymms | first4 = K | last5 = Wakefield | first5 = D | last6 = Dwyer | first6 = J | last7 = Lloyd | first7 = A | author-link7 = Andrew Lloyd | date = 1997 | title = Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome | url =http://dx.doi.org/10.1016/S0002-9343(97)90045-0 | journal = American Journal of Medicine | volume = 103| pages = 38-43 |doi=10.1016/S0002-9343(97)90045-0|via=}}</ref> *1998, Chronic fatigue syndrome: An immunological perspective<ref>Vollmer-Conna U;Lloyd A;Hickie I;Wakefield D, 1998, 'Chronic fatigue syndrome: An immunological perspective', Australian and New Zealand Journal of Psychiatry, vol. 32, pp. 523 - 527</ref> *2003, Identification of ambiguities in the [[Fukuda criteria|1994 chronic fatigue syndrome research case definition]] and recommendations for resolution<ref name="Reeves,2003">{{Citation | last1 = Reeves | first1 = W.C. | author-link = William Reeves | last2 = Lloyd | first2 = A. | author-link2 = Andrew Lloyd | last3 = Vernon | first3 = S.D. | author-link3 = Suzanne Vernon | last4 = Klimas | first4 = N. | author-link4 = Nancy Klimas | last5 = Jason | first5 = L.A. | author-link5 = Leonard Jason | last6 = Bleijenberg | first6 = G. | author-link6 = Gijs Bleijenberg | last7 = Evengard | first7 = B. | author-link7 = Birgitta Evengård | last8 = White | first8 = P.D. | author-link8 = Peter White | last9 = Nisenbaum | first9 = R. | author-link9 = Rosane Nisenbaum | last10 = Unger | first10 = E. | author-link10 = Elizabeth Unger | title = Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution | journal = BMC Health Services Research | volume = 3 | issue = 25 | date = 2003 | doi=10.1186/1472-6963-3-25}}</ref> [https://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-3-25 (Full Text)] *2006, Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: Prospective cohort study<ref>{{Cite journal | last = Hickie | first = Ian | author-link = Ian Hickie | last2 = Davenport | first2 = Tracey | author-link2 = Tracey Davenport | last3 = Wakefield | first3 = Denis | author-link3 = Denis Wakefield | last4 = Vollmer-Conna | first4 = Ute | author-link4 = Uté Vollmer-Conna | last5 = Cameron | first5 = Barbara | author-link5 = Barbara Cameron | last6 = Vernon | first6 = Suzanne D | author-link6 = Suzanne Vernon | last7 = Reeves | first7 = William C | author-link7 = William Reeves | last8 = Lloyd | first8 = Andrew | author-link8 = Andrew Lloyd | date = 2006-09-16 | title = Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study | url = http://www.bmj.com/lookup/doi/10.1136/bmj.38933.585764.AE | journal = BMJ | volume = 333 | issue = 7568 | pages = 575–|doi=10.1136/bmj.38933.585764.ae|pmc=1569956|pmid=16950834|quote=|via=}}</ref> [https://www.researchgate.net/publication/6838807_Post-infective_and_chronic_fatigue_syndromes_precipitated_by_viral_and_non-viral_pathogens_Prospective_cohort_study (Abstract)] *2006, Preliminary evidence of [[mitochondrion|mitochondrial]] dysfunction associated with post-infective fatigue after acute infection with [[Epstein-Barr virus|Epstein Barr Virus]]<ref name="Vernon, 2006" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1373655/ (Full Text)] *2006, Prolonged Illness after Infectious [[Mononucleosis]] Is Associated with Altered Immunity but Not with Increased Viral Load [https://academic.oup.com/jid/article/193/5/664/877191/Prolonged-Illness-after-Infectious-Mononucleosis (Full Text)]<ref name="Cameron,2006" /> *2007, [[Postviral fatigue syndrome|Postinfective fatigue syndrome]] is not associated with altered [[cytokine]] production<ref>Vollmer-Conna U; Cameron B; Hadzi-Pavlovic D; Singletary K; Davenport T; Vernon S; Reeves WC; Hickie I; Wakefield D; Lloyd AR, 2007, 'Postinfective fatigue syndrome is not associated with altered cytokine production', Clinical Infectious Diseases, vol. 45, pp. 732 - 735, http://dx.doi.org/10.1086/520990</ref> *2007, [[Fatigue]]: case definition and guidelines for collection, analysis, and presentation of immunization safety data<ref>{{Cite journal | last = Jones | first = James F. | last2 = Kohl | first2 = Katrin S. | last3 = Ahmadipour | first3 = Nooshin | last4 = Bleijenberg | first4 = Gijs | author-link4 = Gijs Bleijenberg | last5 = Buchwald | first5 = Dedra | author-link5 = Dedra Buchwald | last6 = Evengard | first6 = Birgitta | author-link6 = Birgitta Evengard | last7 = Jason | first7 = Leonard A. | author-link7 = Leonard Jason | last8 = Klimas | first8 = Nancy G. | author-link8 = Nancy Klimas | last9 = Lloyd | first9 = Andrew | author-link9 = Andrew Lloyd | date = Aug 2007 | title = Fatigue: Case definition and guidelines for collection, analysis, and presentation of immunization safety data | url = http://linkinghub.elsevier.com/retrieve/pii/S0264410X07002654 | journal = Vaccine | volume = 25 | issue = 31 | pages = 5685–5696|doi=10.1016/j.vaccine.2007.02.065|issn=0264-410X|via=}}</ref> [https://www.sciencedirect.com/science/article/pii/S0264410X07002654?via%3Dihub (Preview)] *2010, Serum [[Cytokine]] Levels in Postinfective Fatigue Syndrome [https://academic.oup.com/cid/article-lookup/doi/10.1086/649546 (Full Text)]<ref>Barbara Cameron, David L. Hirschberg, Yael Rosenberg-Hassan, Dharam Ablashi, Andrew R. Lloyd. (2010). Serum Cytokine Levels in Postinfective Fatigue Syndrome. Clinical Infectious Diseases, 50 (2): 278-280. doi:10.1086/649546</ref> *2010, [[Autonomic nervous system|Autonomic]] hyper-vigilance in post-infective fatigue syndrome<ref>Kadota Y;Cooper G;Burton AR; Lemon J; Schall U; Lloyd A; Vollmer-Conna U, 2010, 'Autonomic hyper-vigilance in post-infective fatigue syndrome', Biological Psychology, vol. 85, pp. 97 - 103, http://dx.doi.org/10.1016/j.biopsycho.2010.05.009</ref> *2010, Reduced heart rate variability predicts poor sleep quality in a case-control study of chronic fatigue syndrome<ref>Burton AR; Rahman K; Kadota Y; Lloyd A; Vollmer-Conna U, 2010, 'Reduced heart rate variability predicts poor sleep quality in a case-control study of chronic fatigue syndrome', Experimental Brain Research, vol. 204, pp. 71 - 78, http://dx.doi.org/10.1007/s00221-010-2296-1</ref> *2011, Sleep-wake behavior in chronic fatigue syndrome<ref>Rahman K;Burton A;Galbraith S;Lloyd A;Vollmer-Conna U, 2011, 'Sleep-wake behavior in chronic fatigue syndrome', Sleep, vol. 34, pp. 671 - 678</ref> *2012, Reduced Cardiac Vagal Modulation Impacts on Cognitive Performance in Chronic Fatigue Syndrome<ref>Beaumont A;Burton AR;Lemon J;Bennett BK;Lloyd A;Vollmer-Conna U, 2012, 'Reduced Cardiac Vagal Modulation Impacts on Cognitive Performance in Chronic Fatigue Syndrome', PLoS ONE, vol. 7, http://dx.doi.org/10.1371/journal.pone.0049518</ref> *2015, Capturing the [[Post-exertional malaise|post-exertional exacerbation of fatigue]] following physical and cognitive challenge in patients with chronic fatigue syndrome<ref>Keech A;Sandler C;Vollmer-Conna U;Lloyd A;Barry B, 2015, 'Capturing the post-exertional exacerbation of fatigue following physical and cognitive challenge in patients with chronic fatigue syndrome.', in Physiotherapy, Elsevier, Singapore, Vol. 101, pp. e121 - e122, presented at World Congress of Physical Therapy, Singapore, 01 - 04 May 2015, http://dx.doi.org/10.1016/j.physio.2015.03.262</ref> *2016, [https://meaustralia.net/2016/05/09/university-of-nsw-tests-graded-activity-program-on-mild-cfs-patients/ University of NSW tests graded activity program on mild chronic fatigue syndrome patients]<ref>{{Cite news |url =https://meaustralia.net/2016/05/09/university-of-nsw-tests-graded-activity-program-on-mild-cfs-patients/ | title = University of NSW tests graded activity program on mild chronic fatigue syndrome patients | date = 2016-05-09|work=ME Australia | access-date = 2018-10-02|language=en-US}}</ref> *2016, Fatigue Exacerbation by Interval or Continuous [[Exercise]] in Chronic Fatigue Syndrome<ref>Sandler CX, Lloyd AR, Barry BK. (2016). Fatigue Exacerbation by Interval or Continuous Exercise in Chronic Fatigue Syndrome. ''Medicine and Science in Sports Exercise'' 2016 Oct;48(10):1875-85. doi: 10.1249/MSS.0000000000000983</ref> *2016, Outcomes and predictors of response from an optimised, multidisciplinary intervention for chronic fatigue states<ref>Sandler CX;Hamilton BA;Horsfield SL;Bennett BK;Vollmer-Conna U;Tzarimas C;Lloyd AR, 2016, 'Outcomes and predictors of response from an optimised, multidisciplinary intervention for chronic fatigue states', Internal Medicine Journal, vol. 46, pp. 1421 - 1429, http://dx.doi.org/10.1111/imj.13251</ref> *2016, [[Gene expression|Gene Expression]] in Response to Exercise in Patients with Chronic Fatigue Syndrome: A Pilot Study [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031769/ (Full Text)]<ref>Keech, A., Vollmer-Conna, U., Barry, B. K., & Lloyd, A. R. (2016). Gene Expression in Response to Exercise in Patients with Chronic Fatigue Syndrome: A Pilot Study. Frontiers in Physiology, 7, 421. http://doi.org/10.3389/fphys.2016.00421</ref> *2016, Neurocognitive improvements after best-practice intervention for chronic fatigue syndrome: Preliminary evidence of divergence between objective indices and subjective perceptions<ref>Cvejic E;Lloyd AR;Vollmer-Conna U, 2016, 'Neurocognitive improvements after best-practice intervention for chronic fatigue syndrome: Preliminary evidence of divergence between objective indices and subjective perceptions', Comprehensive Psychiatry, vol. 66, pp. 166 - 175, http://dx.doi.org/10.1016/j.comppsych.2016.02.002</ref> *2016, The natural history of acute Q fever: A prospective Australian cohort<ref>{{Cite journal | last = Hopper | first = B. | author-link = | last2 = Cameron | first2 = B. | author-link2 = | last3 = Li | first3 = H. | author-link3 = | last4 = Graves | first4 = S. | author-link4 = | last5 = Stenos | first5 = J. | author-link5 = | last6 = Hickie | first6 = I. | author-link6 = Ian Hickie | last7 = Wakefield | first7 = D. | author-link7 = Denis Wakefield | last8 = Vollmer-Conna | first8 = U. | author-link8 = Uté Vollmer-Conna | last9 = Lloyd | first9 = A.R. | author-link9 = Andrew Lloyd | date = Oct 2016 | title = The natural history of acute Q fever: a prospective Australian cohort | url = https://academic.oup.com/qjmed/article-lookup/doi/10.1093/qjmed/hcw041 | journal = QJM|language=en | volume = 109 | issue = 10 | pages = 661–668|doi=10.1093/qjmed/hcw041|issn=1460-2725|quote=|via=}}</ref> *2017, [[Cytokine]] signature in chronic fatigue syndrome<ref>Roerink ME, Buckland M, Lloyd AR, van der Meer JWM. (2017) Cytokine signature in chronic fatigue syndrome. Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):E9435. doi: 10.1073/pnas.1714011114.</ref> *2017, Autonomic nervous system function, activity patterns, and sleep after physical or cognitive challenge in people with chronic fatigue syndrome<ref>{{Cite journal | last = Cvejic | first = Erin | author-link = | last2 = Sandler | first2 = Carolina X. | author-link2 = | last3 = Keech | first3 = Andrew | author-link3 = | last4 = Barry | first4 = Benjamin K. | author-link4 = | last5 = Lloyd | first5 = Andrew R. | author-link5 = Andrew Lloyd | last6 = Vollmer-Conna | first6 = Uté | author-link6 = Uté Vollmer-Conna | date = Dec 2017 | title = Autonomic nervous system function, activity patterns, and sleep after physical or cognitive challenge in people with chronic fatigue syndrome | url =https://linkinghub.elsevier.com/retrieve/pii/S0022399917304981 | journal = Journal of Psychosomatic Research|language=en | volume = 103 | issue = | pages = 91–94|doi=10.1016/j.jpsychores.2017.10.010|quote=|via=}}</ref> [pubmed:30741357][[pubmed:29167053|(Abstract)]] *2018, Personalised relaxation practice to improve sleep and functioning in patients with chronic fatigue syndrome and [[depression]]: study protocol for a randomised controlled trial<ref>{{Cite journal | last = Macnamara | first = Claire L. | last2 = Cvejic | first2 = Erin | last3 = Parker | first3 = Gordon B. | last4 = Lloyd | first4 = Andrew R. | author-link4 = Andrew Lloyd | last5 = Lee | first5 = Gina | last6 = Beilharz | first6 = Jessica E. | last7 = Vollmer-Conna | first7 = Ute | author-link7 = Uté Vollmer-Conna | date = 2018 | title = Personalised relaxation practice to improve sleep and functioning in patients with chronic fatigue syndrome and depression: study protocol for a randomised controlled trial | url = https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042263/ | journal = Trials | volume = 19 | pages = 371|doi=10.1186/s13063-018-2763-8|via=}}</ref> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042263/ (Full Text)] *2018, The International Collaborative on [[Fatigue]] Following [[Infection]] (COFFI)<ref>{{Cite journal | last = Katz | first = Ben Z | author-link = Ben Katz | last2 = Collin | first2 = Simon M | author-link2 = Simon Collin | last3 = Murphy | first3 = Gabrielle | author-link3 = Gabrielle Murphy | last4 = Moss-Morris | first4 = Rona | author-link4 = Rona Moss-Morris | last5 = Wyller | first5 = Vegard Bruun | author-link5 = Vegard Bruun Wyller | last6 = Wensaas | first6 = Knut-Arne | author-link6 = Knut-Arne Wensaas | last7 = Hautvast | first7 = Jeannine L.A. | author-link7 = Jeannine Hautvast | last8 = Bleeker-Rovers | first8 = Chantal P | author-link8 = Chantal Bleeker-Rovers | last9 = Vollmer-Conna | first9 = Uté | author-link9 = Uté Vollmer-Conna | last10 = Buchwald | first10 = Dedra | author-link10 = Dedra Buchwald | last11 = Taylor | first11 = Renée | author-link11 = Renée Taylor | last12 = Little | first12 = Paul | author-link13 = Paul Little | last13 = Crawley | first13 = Esther | author-link13 = Esther Crawley | last14 = White | first14 = Peter D | author-link14 = Peter White | last15 = Lloyd | first15 = Andrew | author-link15 = Andrew Lloyd | date = 2018-04-03 | title = The international collaborative on fatigue following infection (COFFI) | url = https://www.tandfonline.com/doi/full/10.1080/21641846.2018.1426086|journal = Fatigue: Biomedicine, Health & Behavior |language=en | volume = 6 | issue = 2 | pages = 106–121|doi=10.1080/21641846.2018.1426086|issn=2164-1846|pmc=|pmid=30666281|quote=|via=}}</ref> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333416/ (Full text)] *2019, The Invisible Burden of Chronic Fatigue in the Community: a Narrative Review<ref>{{Cite journal | last = Fatt | first = Scott J. | author-link = | last2 = Cvejic | first2 = Erin | author-link2 = | last3 = Lloyd | first3 = Andrew R. | author-link3 = Andrew Lloyd | last4 = Vollmer-Conna | first4 = Ute | author-link4 = Uté Vollmer-Conna | last5 = Beilharz | first5 = Jessica Elise | author-link5 = | date = Feb 2019 | title = The Invisible Burden of Chronic Fatigue in the Community: a Narrative Review | url =http://link.springer.com/10.1007/s11926-019-0804-2 | journal = Current Rheumatology Reports|language=en | volume = 21 | issue = 2| pages=|doi=10.1007/s11926-019-0804-2|issn=1523-3774|quote=|via=}}</ref> [[pubmed:30741357|(Abstract)]] ==Talks and interviews== * Apr 22, 2014, [https://www.youtube.com/watch?v=BgWgX5F5WUM Talk to Coogee Owls ME/CFS Support Group at Randwick, Sydney] *Sep 1-2, 2014, [[UK CFS/ME Research Collaborative]] Conference - Talk title: "Acute infection & post-infective fatigue as a model for CFS"<ref>https://www.actionforme.org.uk/uploads/pdfs/cmrc-2014-conference-report-final.pdf</ref> ==Online presence== *[https://medicalsciences.med.unsw.edu.au/people/professor-andrew-lloyd UNSW bio page] ==See also== *[[Australia]] ==Learn more== * 2012, [http://phoenixrising.me/research-2/the-dubbo-studies-a-model-of-post-infective-fatigue-emerging/model-of-post-infective-fatigue-forming-the-dubbo-studies "Model of Post Infective Fatigue Forming: the Dubbo Studies"] in [[Phoenix Rising]] *2015, [https://www.healthrising.org/blog/2015/05/16/the-decline-and-fall-of-an-mecfs-researcher-the-case-of-andrew-lloyd/ "The Decline and Fall of an ME/CFS Researcher? the Case of Andrew Lloyd"] by [[Cort Johnson]] for [[Health Rising]] *2018, [http://www.virology.ws/2018/04/04/trial-by-error-a-post-about-andrew-lloyd/ Trial By Error: A Post About Andrew Lloyd] ==References== <references> <ref name="Cameron,2006">{{Citation | last = Cameron | first1 = Barbara | author-link1 =Barbara Cameron | last2 =Bharadwaj | first2 = Mandvi | author-link2 =Mandvi Bharadwaj | last3 =Burrows | first3 = Jacqueline| author-link3 = Jacqueline | last4 = Fazou | first4 = Chrysa| author-link4 =Chrysa Fazou | last5 = Wakefield | first5 = Denis| author-link5 =Denis Wakefield | last6 = Hickie | first6 = Ian | author-link6 =Ian Hickie | last7 =Ffrench | first7 = Rosemary| author-link7 =Rosemary Ffrench | last8 =Khanna | first8 = Rajiv| author-link8 =Rajiv Khanna | last9 = Lloyd | first9 = Andrew | author-link9 = Andrew Lloyd | title = Prolonged Illness after Infectious Mononucleosis Is Associated with Altered Immunity but Not with Increased Viral Load | journal = Journal Infectious Disease | volume = 193 | issue = 5 | page = 664-671 | date = 2006 | pmid = | doi = 10.1086/500248 }}</ref> <ref name="lloyd1990">{{Citation| issn = 0002-9343| volume = 89 | issue = 5| pages = 561–568| last1 = Lloyd | first1 = A. | last2 = Hickie | first2 = I. | last3 = Wakefield | first3 = D. | last4 = Boughton | first4 = C. | last5 = Dwyer | first5 = J.| title = A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome| journal = The American Journal of Medicine | date = November 1990 | pmid = 2146875}}</ref> <ref name="Vernon, 2006">{{Cite journal | last = Vernon | first1 = SD | author-link1 = Suzanne Vernon | last2 = Whistler | first2 = T | author-link2 = | last3 = Cameron | first3 = B | author-link3 = | last4 = Hickie | first4 = IB | author-link4 = | last5 = Reeves | first5 = WC | author-link5 = William Reeves | last6 = Lloyd | first6 = A | author-link6 = Andrew Lloyd | title = Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus | journal = BMC Infectious Diseases | volume = 6 | issue = 15 | page = | date = 2006 | pmid = 16448567 | doi = 10.1186/1471-2334-6-15 }}</ref> </references> [[Category:Researchers]] [[Category:Australia researchers]]
Summary:
Please make sure your edits are consistent with
MEpedia's guidelines
.
By saving changes, you agree to the
Terms of use
, and you irrevocably agree to release your contribution under the
CC BY-SA 3.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)
Templates used on this page:
Template:Citation
(
edit
)
Template:Cite journal
(
edit
)
Template:Cite news
(
edit
)
Template:Cite web
(
edit
)
Module:Citation/CS1
(
edit
)
Module:Citation/CS1/COinS
(
edit
)
Module:Citation/CS1/Configuration
(
edit
)
Module:Citation/CS1/Date validation
(
edit
)
Module:Citation/CS1/Identifiers
(
edit
)
Module:Citation/CS1/Utilities
(
edit
)
Module:Citation/CS1/Whitelist
(
edit
)
Module:No globals
(
edit
)
Navigation
Navigation
Skip to content
Main page
Browse
Become an editor
Random page
Popular pages
Abbreviations
Glossary
About MEpedia
Links for editors
Contents
Guidelines
Recent changes
Pages in need
Search
Help
Wiki tools
Wiki tools
Special pages
Page tools
Page tools
User page tools
More
What links here
Related changes
Page information
Page logs